I was not positive on CMED when it was on IPO. I did not understand why CMED could get to 40s. I was wrong, so I have no opinion about CMED. Just present some old info about this co when I need to clean some old paper.

Business areas
1. HIFY (超声刀,象伽玛刀)destroys cancer cells.
2. ECLIA, electrochemiluminescence immunoassay, 萤光免疫检测之类

rev:

2003,2004,2005,2006(est,1$=7.82) in RMB in thousands

63716,110750, 217547, 516000

earning increase somewhat proportionally with rev

I do not understand ECLIA well, however, do not believe HIFY is a great for cancer treatment. But looks from the info I can get, it seems CMED is doing OK. Confused so will forget it.